Read the status first
Peptide is a category, not a guarantee. Identify the exact substance, the proposed use and the country. Distinguish approved medicines from investigational compounds.
Check what was actually studied
Ask whether a claim comes from human trials, animal work or a seller’s testimonial. Look for the studied outcome, trial size, comparison group and published limitations.
Understand the label
FDA warns about unapproved GLP-1 products and says retatrutide and cagrilintide cannot be used in compounding under US federal law. A research label does not establish a product’s suitability for personal treatment.
The useful next question
Ask a qualified clinician about established alternatives and relevant registered trials. This guide provides no sourcing links or self-experimentation protocols.
Read the source material
Checked 29 October 2026. Country-specific approvals and service availability can change. Discuss personal treatment decisions with an appropriately qualified professional.